Rep. Waxman asks EPA Administrator Christine Todd Whitman to release the information that convinced the EPA to reject a proposal that would have protected public health and the environment better than the President's Clear Skies Initiative.
On Aug. 26, Rep. Waxman wrote HHS Secretary Tommy Thompson to protest a dangerous FDA plan to make colored contact lenses available to children and others without medical supervision or manufacturing standards. Since then, Rep. Waxman's position that colored contact lenses are medical devices has received strong support from the major organizations representing eye health professionals, pediatricians, the major manufacturers of colored lenses now legally available in the United States, and Prevent Blindness, a national advocacy organization devoted to eye health and safety. Sen. Edward Kennedy has also written in opposition to the FDA plan.
In a letter to Homeland Security Director Tom Ridge and Transportation Secretary Mineta, Rep. Waxman and Rep. Oberstar express concern that the Transportation Security Administration (TSA) has been, and continues to be, severely deficient in screening luggage for explosives at our nation’s airports. According to recent data, TSA is using less than 3% of existing explosive detection machines at maximum capacity levels.
Rep. Waxman and Sen. Dick Durbin wrote the Federal Trade Commission to urge that the agency not permit smokeless tobacco to be marketed as a "safer" alternative to smoking. Citing new evidence that smokeless tobacco products are being marketed heavily in youth-oriented magazines, Rep. Waxman and Sen. Durbin also asked the National Association of Attorneys General to investigate the compliance of the United States Smokeless Tobacco Company with the multi-state Master Settlement Agreement which governs the way tobacco products are advertised and marketed in the U.S.
As criticism of the tobacco industry has accelerated in recent years and calls for product regulation have grown, tobacco companies have defended themselves by saying they are now "responsible" corporations that aim to communicate honestly about their products. A new report released by Rep. Waxman examines recently submitted filings by the five largest cigarette manufacturers in the civil suit brought by the United States Department of Justice to evaluate the truthfulness of company statements.
Rep. Waxman and other members have written Department of Health and Human Services Secretary Tommy Thompson to share their concerns about ephedara-containing dietary supplements.
The Subcommittee on Government Efficiency, Financial Management and Intergovernmental Relations held a hearing on H.R. 2693, the Holocaust Victims Insurance Relief Act of 2001.
A report released by Rep. Waxman analyzes the impact of federal deficits on the Social Security contributions of working families in Los Angeles County.
In a letter to HHS Secretary Thompson, Rep. Waxman reveals that FDA enforcement actions against drug manufacturers for false or misleading claims in drug advertisements have dropped by 70% under the Bush Administration.
A report released by Sen. Durbin, Rep. Waxman, and Rep. Davis examines 13,000 adverse event reports received by Metabolife, the largest manufacturer of ephedra-containing dietary supplements. The records include nearly 2,000 reports of significant adverse reactions including deaths, heart attacks, and strokes
In an Oct. 1 letter to EPA Administrator Whitman, Rep. Waxman asked why technical data submitted to Congress was changed to minimize the risk that hydraulic fracturing, an oil and gas extraction technique promoted by Halliburton, would contaminate underground sources of drinking water. In a follow-up letter to Administrator Whitman, Rep. Waxman details contradictions in EPA statements on whether EPA changed its data on hydraulic fracturing in a way that benefits Halliburton.
Rep. Waxman sent a letter to Energy and Commerce Chairman Billy Tauzin and Energy and Air Quality Subcommittee Chairman Joe Barton regarding their insistence that new controversial electricity laws apply to each of the contiguous states but Texas.
In an advisory to U.S. consumers, Deputy Commissioner Dr. Lester M. Crawford warned of the dangers of unsupervised use of colored contact lenses and promised the agency would use "the full range of its statutory authorities" to assure that colored lenses are safe and dispensed only with a prescription. Rep. Waxman will continue to closely monitor FDA actions in this area.
A new report released by Rep. Ciro Rodriguez and Rep. Gene Green found that the vast majority of Texas nursing homes are understaffed and fail to comply with federal standards.
Since November 1999, the Special Investigations Division has prepared reports for members on nursing home conditions in Los Angeles, Chicago, San Francisco, Texas, Florida, Oklahoma, and other areas. These reports have confirmed that many nursing homes violate federal health and safety standards and that these violations often involve the serious neglect and mistreatment of residents.
Speaking on the House floor, Rep. Waxman said that while it is clear that federal departments are not working together as they should to protect our nation, the Homeland Security Act of 2002 has serious flaws and may well cause more problems than it solves.
A new minority staff fact sheet summarizes the numerous special-interest provisions buried in the homeland security bill (H.R. 5710) that limit the liability of drug companies, airline carriers, airline security companies, and other manufacturers. Rep. Waxman writes OMB Director Daniels to inquire about the provisions that would change the Vaccine Injury Compensation Program in a way that benefits manufacturers Eli Lilly and Dow Chemical, and to HHS Secretary Thompson to call his attention to the provisions that provide liability protection for makers of the smallpox vaccine, yet fail to provide appropriate compensation for those who may be injured by the vaccine.
Rep. Waxman writes HHS Secretary Thompson to ask why the U.S. government is objecting to a draft report from the World Health Organization that calls for a reduction in soft drink consumption as part of a global strategy to fight obesity.
Continuing the Committee's investigation, Reps. Waxman and Burton have sent additional letters requesting information relevant to the resolution of insurance claims of Holocaust victims.
Rep. Waxman writes Environmental Protection Agency Administrator Christine Whitman expressing his concern that, at the behest of the pesticide industry, the Administrator was allowing human testing results to be used in the determination of pesticide toxicity. Rep. Waxman’s letter requests that Administrator Whitman provide him with details on the use of these human testing results and the decision-making process that allowed their use.
A federal judge dismissed the lawsuit filed by the General Accounting Office in which it sought to obtain access to records of the White House energy task force chaired by Vice President Cheney.
Rep. Waxman and Rep. Doggett call for a full investigation into a midnight trade deal by U.S. Trade Representative Robert Zoellick that will phase out tariffs on U.S. cigarettes sold in Chile, an abandonment of the Administration’s previously stated position that cigarettes would not be included in the trade negotiations.
A report released by Reps. Waxman and Solis finds that gravel pit mining in the San Gabriel Valley of California contributes to air pollution in the local area, and that environmental regulators lack basic information about the magnitude of the environmental risk from the mining operations.
Rep. Waxman and other members have written to HHS Secretary Thompson to protest the alteration and removal of important public health information from federal websites concerning the use of condoms to prevent sexually transmitted diseases and the alleged association between abortion and breast cancer. The Department of Health and Human Services removed scientific fact sheets from its websites earlier this year, and has now reposted significantly altered versions which distort and suppress scientific information for ideological purposes.
Displaying Items 101 to 125 of 126: